We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks Industry Feedback on Industry Barriers to Exposure-Response Analyses
FDA Seeks Industry Feedback on Industry Barriers to Exposure-Response Analyses
The FDA requested stakeholder feedback on its 2003 guidance on exposure-response analyses — prompted by PDUFA VI provisions on advancing model-informed drug development.